Molecular Targets in Alzheimer's Disease

被引:25
|
作者
Bjorklund, Geir [1 ]
Aaseth, Jan [2 ,3 ]
Dadar, Maryam [4 ]
Chirumbolo, Salvatore [5 ]
机构
[1] Council Nutr & Environm Med, Toften 24, N-8610 Mo I Rana, Norway
[2] Inland Norway Univ Appl Sci, Fac Hlth & Social Sci, Elverum, Norway
[3] Innlandet Hosp Trust, Dept Res, Brumunddal, Norway
[4] Razi Vaccine & Serum Res Inst, AREEO, Karaj, Iran
[5] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy
关键词
Alzheimer's disease; Amyloid beta; Tau protein; Oxidative stress; AMYLOID-BETA-PEPTIDE; PROTEIN-TYROSINE PHOSPHATASES; MITOCHONDRIAL TRANSFER-RNAS; HUMAN PRESEQUENCE PROTEASE; CHYMOTRYPSIN-LIKE ACTIVITY; NITRIC-OXIDE SYNTHASE; OXIDATIVE STRESS; 20S PROTEASOME; REVERSIBLE INACTIVATION; BRAIN MITOCHONDRIA;
D O I
10.1007/s12035-019-1563-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is known as a devastating neurodegenerative disorder in aged subjects, which is related to multiple heterogeneous genetic factors. The two basic pathological aspects of AD are related to amyloid beta (A beta) peptides and tau proteins. Some researchers have demonstrated plaques and tangles as apparently primary lesions. Also, experimental data propose that these two lesions are intimately related. In the present review, we highlight some molecular mechanisms linking tau and A beta toxicities involving oxidative stress, aging, A beta turnover, the contribution of thiol groups, and the role mitochondrial activities in the AD pathogenesis. Understanding the interplay of these mechanisms as parts of common pathophysiological pathways could reveal molecular targets to control or even treat AD.
引用
收藏
页码:7032 / 7044
页数:13
相关论文
共 50 条
  • [31] New kinase targets for Alzheimer's disease
    Flight, Monica Hoyos
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (10) : 739 - 739
  • [32] Metal and inflammatory targets for Alzheimer's disease
    Rogers, JT
    Lahiri, DK
    [J]. CURRENT DRUG TARGETS, 2004, 5 (06) : 535 - 551
  • [33] Alzheimer's Disease: Targets For Drug Development
    Larner, A. J.
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2002, 2 (01) : 3 - 11
  • [34] New kinase targets for Alzheimer's disease
    Monica Hoyos Flight
    [J]. Nature Reviews Drug Discovery, 2013, 12 : 739 - 739
  • [35] Alzheimer's Disease and Cancer: Common Targets
    Yang, Xueqing
    Dai, Jinlian
    Wu, Chenglong
    Liu, Zongliang
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (10) : 983 - 1000
  • [36] Secretases as therapeutic targets for Alzheimer's disease
    Woo, Ha-Na
    Baik, Sang-Ha
    Park, Jong-Sung
    Gwon, A-Ryeong
    Yang, Sunghee
    Yun, Young-Kwang
    Jo, Dong-Gyu
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 404 (01) : 10 - 15
  • [37] New Therapeutic Targets in Alzheimer's Disease
    Coman, Horia
    Nemes, Bogdan
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2017, 11 (01) : 2 - 6
  • [38] Druggable targets for the immunopathy of Alzheimer's disease
    Weaver, Donald F.
    [J]. RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1645 - 1661
  • [39] Possible treatment targets in Alzheimer’s disease
    A. Pryce Roberts
    N. P. Robertson
    [J]. Journal of Neurology, 2013, 260 (12) : 3193 - 3196
  • [40] Peptides as drug targets for Alzheimer's disease
    Gozes, I
    Spier, AD
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 344 - 344